CML Support Groups: Members of the CML Advocates Network

The CML Advocates Network connects patient organisations supporting patients and families affected with Chronic Myeloid Leukemia (CML)

If your group is not listed here, please register. If details have changed, please contact us.

Bosnia and Herzegovina: Organisation of Leukemia Patients "Osmijeh" Tuzla

Contact information

Trnovac bb

75000 Tuzla

Bonsia Herzegovina



Key contact

Edib Hadžimuhamedović, President of the Organisation

Brief description of organization

The organisation was founded in 2013 with the goal of helping patients in fulfilling their rights to treatment. It's oficially registered as a non-governmental, non-profit organisation covering the regions of Tuzla and Posavina Cantons as well as District of Brčko. Our membership include patients, patients' friends and family, hematologists and head nurses from the UKC Tuzla's hematology department.

Key objectives and initiatives

Our main objective is to provide patients with care, treatment, and better and more humane life conditions. We fight for quality and adequate treatment. We try to keep our patients up-to-date with the improvements in treatment. We try to help new patients learn to cope with the disease and give them and their families support. We organise meetings with similar organisations, exhange experiences and keep constant contact with state-level health institutions demanding better treatment. We raise awareness about the disease by marking the International CML Day. To conclude, Osmijeh does everything we can to make CML patients' lives as less difficult as we can.

Number of members or patients the organisation represents

42 (Dec 2014)


EU e-Privacy Directive

Please donate!

Please donate!

Tweet Feed

Check our global database run by patients for #patients with 51 current #CML #clinicaltrials which have been initia……

Thursday, 24 May 2018

“When looking at statistics, it is important to remember that we are not talking about decimal points on a graph, b……

Retweeted Thursday, 24 May 2018

From 26 April “Sprycel is indicated for the treatment of paediatric patients with: newly diagnosed Ph+ CML in chron……

Retweeted Saturday, 19 May 2018